None, non-interventional study
OtherNot applicable, non-interventional study
NCT Number: NCT03144570
Prospective observational multicenter study in European ICUs. All patients admitted to the ICU for probable or confirmed Acute encephalitis (2013 IDSA - Infectious Disease Society of America criteria) will be included. Factors associated with a poor prognosis will be identified by multivariate analysis using a logistic regression.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Medical University of Innsbruck, Innsbruck, Austria
Primary objective :
evaluate the correlation between mRs score and the baseline characteristics Functional outcomes will be evaluated using the modified Rankin score (mRS) score, which is one of the most frequently used scores in acute neurological diseases [18]. A poor outcome will be defined by a mRS score > 2 (functional dependence or death). The investigator usually evaluates this score if the patient is still in the hospital 90 days after admission. Patients discharged from hospital within 90 days following ICU admission without major disability (mRS 0, 1 or 2) are considered to have a good outcome. Patients discharged within 90 days with a disability will be classified for the study according to the latest available data. Patients will not be contacted directly by the investigator for the study purposes.
Secondary objectives :
To identify additional prognosis factors : the clinical, radiological, biological and neurophysiological factors associated with poor outcome for patients admitted to the ICU with AE
The cause of death will be categorized into 2 categories:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Not applicable, non-interventional study
Time frame: Day 90
The modified Rankin Scale (mRS) is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. It has become the most widely used clinical outcome measure for stroke clinical trials.
Time frame: Day 28
Rate of death at day 28
Time frame: Day 90
Septic shock, hyponatremia
Time frame: Day 90
Documented seizures, status epilepticus, Diffuse cerebral edema, herniation, Ischemia, cerebral hemorrhage
Time frame: Day 90
List of all available methods of intracranial pressure monitoring used in study sites and their outcome
Time frame: Day 90
Monitoring of neurosurgery to identify additional prognosis factors
ICUREsearch
Industry
Acronym: EURECA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06067750
Acute Ischemic Stroke, Brain Diseases
Nottingham, Nottinghamshire, United Kingdom
View Trial DetailsNCT04325685
Abdominal Sepsis, Accidental Injuries
Severodvinsk, Arkhangelskaya oblast, Russia
View Trial DetailsNCT04323150
Abdominal Sepsis, Accidental Injuries
Severodvinsk, Russia
View Trial DetailsNCT03826056
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Lebanon, New Hampshire, United States
View Trial Details